Gate2Brain

About:

Gate2Brain is a biotech company to improve drug delivery with peptide-based patented technology.

Top Investors: European Innovation Council, BStartup

Description:

Gate2Brain is an early-stage biotech company launched to improve drug delivery across biological barriers through the use of a radically innovative peptide-based patented technology. Its technology aims to transport drugs to the brain, increasing the efficiency and reducing the side effects of treatments for brain diseases.

Total Funding Amount:

2.57M EUR

Headquarters Location:

Barcelona, Catalonia, Spain

Founded Date:

2020-01-01

Founders:

Gloria Sancliments, Meritxell Teixido

Number of Employees:

1-10

Last Funding Date:

2022-10-05

IPO Status:

Private

Industries: